Immunotherapy of Cancer: An Innovative Treatment Comes of Age
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Tokyo
Springer Japan
2016
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext Abstract Inhaltsverzeichnis |
| Beschreibung: | 1 Online Ressource (IX, 358 p. 46 illus., 8 illus. in color) |
| ISBN: | 9784431550310 |
| DOI: | 10.1007/978-4-431-55031-0 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043422505 | ||
| 003 | DE-604 | ||
| 005 | 20160502 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160302s2016 |||| o||u| ||||||eng d | ||
| 020 | |a 9784431550310 |c Online |9 978-4-431-55031-0 | ||
| 024 | 7 | |a 10.1007/978-4-431-55031-0 |2 doi | |
| 035 | |a (OCoLC)943817165 | ||
| 035 | |a (DE-599)BVBBV043422505 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Immunotherapy of Cancer |b An Innovative Treatment Comes of Age |c Yoshiyuki Yamaguchi, ed. |
| 264 | 1 | |a Tokyo |b Springer Japan |c 2016 | |
| 300 | |a 1 Online Ressource (IX, 358 p. 46 illus., 8 illus. in color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Cancer research | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Medicine & Public Health | |
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a Medizin | |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Yamaguchi, Yoshiyuki |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-4-431-55030-3 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-4-431-55031-0 |x Verlag |3 Volltext |
| 856 | 4 | 2 | |m Springer Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Abstract |
| 856 | 4 | 2 | |m Springer Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_2016 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028840398 | ||
| 966 | e | |u https://doi.org/10.1007/978-4-431-55031-0 |l UBR01 |p ZDB-2-SME |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176016793403392 |
|---|---|
| adam_text | IMMUNOTHERAPY OF CANCER
/
: 2016
ABSTRACT / INHALTSTEXT
THIS TIMELY BOOK, PUBLISHED JUST AS CANCER IMMUNOTHERAPY COMES OF AGE,
SUMMARIZES THE RATIONALE, PRESENT STATUS, AND FUTURE PERSPECTIVE FOR
CANCER IMMUNOTHERAPY. INCLUDED ARE EXPLANATIONS OF THE CONSTITUTION OF
THE IMMUNE SYSTEM AND IMMUNOCHECKPOINTS, THE MECHANISM OF ANTIGEN
PRESENTATION AND RECOGNITION, VALUABLE MODALITIES, CLINICAL TRIALS AND
GUIDANCE, PERSONALIZATION, AND BIOMARKERS, ALL OF WHICH ARE ESSENTIAL
FOR UNDERSTANDING THE SUCCESS OF CANCER IMMUNOTHERAPY.THIS INNOVATIVE
THERAPY HAS BEEN INVESTIGATED WORLDWIDE AS THE FOURTH LINE OF CANCER
TREATMENT AFTER THE STANDARD TREATMENTS OF SURGERY, CHEMOTHERAPY, AND
RADIOTHERAPY. THE PROGRESS IN FUNDAMENTAL UNDERSTANDING OF TUMOR
IMMUNOLOGY AND THE RECENT ADVANCES IN CLINICAL TRIALS HAVE OPENED NEW
AVENUES WITH A CANCER VACCINE IN 2010 AND IMMUNOCHECKPOINT MODULATION IN
2011, WITH THEIR APPROVAL ALREADY GRANTED IN THE UNITED STATES. TODAY,
THERE ARE NO DOUBTS, EVEN AMONG EXPERTS IN CANCER CHEMOTHERAPY AND
RADIOTHERAPY, THAT THE IMMUNE SYSTEM PLAYS A VITAL ROLE IN TUMOR
ERADICATION. FOLLOWING AMERICAN APPROVAL,MANY CLINICAL TRIALS OF
CANCER IMMUNOTHERAPY ARE BEING CONDUCTED. WITH THIS BOOK THE READER
WILL READILY UNDERSTAND THE PARADIGM SHIFT IN CANCER TREATMENT AND WILL
REALIZE THE IMPORTANCE OF CANCER IMMUNOTHERAPY. THE GREAT VALUE OF
IMMUNOTHERAPY WILL BE OBVIOUS, NOT ONLY FOR TUMOR SHRINKAGE BUT FOR
PROLONGING PATIENT SURVIVAL
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
IMMUNOTHERAPY OF CANCER
/
: 2016
TABLE OF CONTENTS / INHALTSVERZEICHNIS
PART I OVERVIEW, HISTORY, CLASSIFICATION
CHAPTER 1 OVERVIEW OF CURRENT CANCER IMMUNOTHERAPY
PART II BRMS AND CRUDE AGENTS
CHAPTER 2 BACTERIAL PREPARATIONS
CHAPTER 3 POLYSACCHARIDES
CHAPTER 4 BCG
PART III CYTOKINES
CHAPTER 5 ΑΒ-T CELLS
CHAPTER 6 NKT CELL-BASED IMMUNOTHERAPY
CHAPTER 7 NATURAL KILLER CELLS
CHAPTER 8 ΓΔ T CELL-BASED CANCER IMMUNOTHERAPY
CHAPTER 9 GENETICALLY ENGINEERED T CELLS
PART IV VACCINE THERAPY
CHAPTER 10 PEPTIDE VACCINE
CHAPTER 11 PERSONALIZED PEPTIDE VACCINE
CHAPTER 12 WT1 PEPTIDE VACCINE FOR THE TREATMENT OF MALIGNANCIES
CHAPTER 13 PROTEIN VACCINE
CHAPTER 14 DENDRITIC CELL-BASED VACCINE FOR CANCER
PART V IMMUNOADJUVANTS
CHAPTER 15 CPG MOTIF
CHAPTER 16 PATTERN RECOGNITION BY DENDRITIC CELLS AND ITS APPLICATION TO
VACCINE ADJUVANT FOR ANTITUMOR IMMUNOTHERAPY
CHAPTER 17 NOVEL ADJUVANTS
PART VI IMMUNOCHECKPOINTS
CHAPTER 18 ANTI-CTLA-4 AB
CHAPTER 19 ANTI-PD-1, PD-L1 AB
CHAPTER 20 NOVEL TARGETS OF IMMUNE INHIBITORY AND STIMULATORY CO-SIGNALS
PART VII REGULATION OF IMMUNOSUPPRESSION
CHAPTER 21 REGULATORY T CELLS
CHAPTER 22 MDSC: MYELOID-DERIVED SUPPRESSOR CELLS
PART VIII IMMUNE-RELATED RESPONSE CRITERIA AND GUIDANCE FOR CLINICAL
TRIALS
CHAPTER 23 IMMUNE-RELATED RESPONSE CRITERIA AND GUIDANCE FOR CLINICAL
TRIALS
PART IX PERSONALIZED IMMUNOTHERAPY
CHAPTER 24 ERSONALIZED CANCER IMMUNOTHERAPY: IMMUNE BIOMARKERS AND
COMBINATION IMMUNOTHERAPY
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV043422505 |
| classification_rvk | XH 3200 |
| collection | ZDB-2-SME |
| ctrlnum | (OCoLC)943817165 (DE-599)BVBBV043422505 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-4-431-55031-0 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02191nmm a2200517zc 4500</leader><controlfield tag="001">BV043422505</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160502 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160302s2016 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9784431550310</subfield><subfield code="c">Online</subfield><subfield code="9">978-4-431-55031-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-4-431-55031-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)943817165</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043422505</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunotherapy of Cancer</subfield><subfield code="b">An Innovative Treatment Comes of Age</subfield><subfield code="c">Yoshiyuki Yamaguchi, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Tokyo</subfield><subfield code="b">Springer Japan</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online Ressource (IX, 358 p. 46 illus., 8 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine & Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamaguchi, Yoshiyuki</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-4-431-55030-3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-4-431-55031-0</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Abstract</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2016</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028840398</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-4-431-55031-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043422505 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:25:29Z |
| institution | BVB |
| isbn | 9784431550310 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028840398 |
| oclc_num | 943817165 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online Ressource (IX, 358 p. 46 illus., 8 illus. in color) |
| psigel | ZDB-2-SME ZDB-2-SME_2016 |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Springer Japan |
| record_format | marc |
| spelling | Immunotherapy of Cancer An Innovative Treatment Comes of Age Yoshiyuki Yamaguchi, ed. Tokyo Springer Japan 2016 1 Online Ressource (IX, 358 p. 46 illus., 8 illus. in color) txt rdacontent c rdamedia cr rdacarrier Medicine Cancer research Immunology Oncology Medicine & Public Health Cancer Research Medizin Immuntherapie (DE-588)4026640-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Immuntherapie (DE-588)4026640-0 s DE-604 Yamaguchi, Yoshiyuki Sonstige oth Erscheint auch als Druckausgabe 978-4-431-55030-3 https://doi.org/10.1007/978-4-431-55031-0 Verlag Volltext Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Abstract Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Immunotherapy of Cancer An Innovative Treatment Comes of Age Medicine Cancer research Immunology Oncology Medicine & Public Health Cancer Research Medizin Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4026640-0 (DE-588)4073781-0 |
| title | Immunotherapy of Cancer An Innovative Treatment Comes of Age |
| title_auth | Immunotherapy of Cancer An Innovative Treatment Comes of Age |
| title_exact_search | Immunotherapy of Cancer An Innovative Treatment Comes of Age |
| title_full | Immunotherapy of Cancer An Innovative Treatment Comes of Age Yoshiyuki Yamaguchi, ed. |
| title_fullStr | Immunotherapy of Cancer An Innovative Treatment Comes of Age Yoshiyuki Yamaguchi, ed. |
| title_full_unstemmed | Immunotherapy of Cancer An Innovative Treatment Comes of Age Yoshiyuki Yamaguchi, ed. |
| title_short | Immunotherapy of Cancer |
| title_sort | immunotherapy of cancer an innovative treatment comes of age |
| title_sub | An Innovative Treatment Comes of Age |
| topic | Medicine Cancer research Immunology Oncology Medicine & Public Health Cancer Research Medizin Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Medicine Cancer research Immunology Oncology Medicine & Public Health Cancer Research Medizin Immuntherapie Krebs Medizin |
| url | https://doi.org/10.1007/978-4-431-55031-0 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028840398&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT yamaguchiyoshiyuki immunotherapyofcanceraninnovativetreatmentcomesofage |